Which has higher earnings and valuation, SEER or TKNO?

Alpha Teknova has higher revenue and earnings than Seer. Alpha Teknova is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Seer $16.58M 6.95 -$73.60M -$1.22 N/A Alpha Teknova $40.52M 10.31 -$17.26M -$0.31 N/A

Is SEER or TKNO more profitable?

Alpha Teknova has a net margin of -38.37% compared to Seer's net margin of -478.05%. Alpha Teknova's return on equity of -24.94% beat Seer's return on equity. Company Net Margins Return on Equity Return on Assets Seer -478.05% -27.23% -23.99% Alpha Teknova -38.37% -24.94% -16.53%

Which has preferable earnings & valuation, SEER or SLP?

Simulations Plus has higher revenue and earnings than Seer. Seer is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Seer $16.58M 6.95 -$73.60M -$1.22 N/A Simulations Plus $82.06M 4.56 -$64.72M $0.40 46.25

Is SEER or SLP more profitable?

Simulations Plus has a net margin of 9.88% compared to Seer's net margin of -478.05%. Simulations Plus' return on equity of 13.50% beat Seer's return on equity. Company Net Margins Return on Equity Return on Assets Seer -478.05% -27.23% -23.99% Simulations Plus 9.88% 13.50% 12.45%

Which has stronger valuation & earnings, SEER or QSI?

Seer has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Seer $16.58M 6.95 -$73.60M -$1.22 N/A Quantum-Si $2.44M 124.69 -$101.34M -$0.46 N/A

Is SEER or QSI more profitable?

Seer has a net margin of -478.05% compared to Quantum-Si's net margin of -6,138.26%. Seer's return on equity of -27.23% beat Quantum-Si's return on equity. Company Net Margins Return on Equity Return on Assets Seer -478.05% -27.23% -23.99% Quantum-Si -6,138.26% -47.12% -43.18%

Is LAB or SEER more profitable?

Standard BioTools has a net margin of 100.36% compared to Seer's net margin of -478.05%. Standard BioTools' return on equity of -7.57% beat Seer's return on equity. Company Net Margins Return on Equity Return on Assets Standard BioTools 100.36% -7.57% -6.14% Seer -478.05% -27.23% -23.99%

Seer (SEER) Competitors

$2.06 -0.02 (-0.72%)

As of 01:59 PM Eastern

Compare

SEER vs. TKNO, SLP, QSI, NAUT, and LAB

Should you buy Seer stock or one of its competitors? Seer's main competitors and comparable companies include Alpha Teknova (TKNO), Simulations Plus (SLP), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), and Standard BioTools (LAB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Seer compare to Alpha Teknova?

Seer (NASDAQ:SEER) and Alpha Teknova (NASDAQ:TKNO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Alpha Teknova has a net margin of -38.37% compared to Seer's net margin of -478.05%. Alpha Teknova's return on equity of -24.94% beat Seer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Seer	-478.05%	-27.23%	-23.99%
Alpha Teknova	-38.37%	-24.94%	-16.53%

Seer presently has a consensus price target of $4.00, suggesting a potential upside of 92.31%. Alpha Teknova has a consensus price target of $8.75, suggesting a potential upside of 12.32%. Given Seer's stronger consensus rating and higher probable upside, research analysts plainly believe Seer is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Seer	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Alpha Teknova had 2 more articles in the media than Seer. MarketBeat recorded 3 mentions for Alpha Teknova and 1 mentions for Seer. Seer's average media sentiment score of 1.82 beat Alpha Teknova's score of 0.95 indicating that Seer is being referred to more favorably in the media.

Company	Overall Sentiment
Seer	Very Positive
Alpha Teknova	Positive

75.2% of Seer shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 11.3% of Seer shares are owned by insiders. Comparatively, 13.2% of Alpha Teknova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Seer has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

Alpha Teknova has higher revenue and earnings than Seer. Alpha Teknova is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Seer	$16.58M	6.95	-$73.60M	-$1.22	N/A
Alpha Teknova	$40.52M	10.31	-$17.26M	-$0.31	N/A

Summary

Alpha Teknova beats Seer on 10 of the 17 factors compared between the two stocks.

How does Seer compare to Simulations Plus?

Seer (NASDAQ:SEER) and Simulations Plus (NASDAQ:SLP) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Seer has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market. Comparatively, Simulations Plus has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

Simulations Plus has a net margin of 9.88% compared to Seer's net margin of -478.05%. Simulations Plus' return on equity of 13.50% beat Seer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Seer	-478.05%	-27.23%	-23.99%
Simulations Plus	9.88%	13.50%	12.45%

Seer presently has a consensus price target of $4.00, indicating a potential upside of 92.31%. Simulations Plus has a consensus price target of $17.25, indicating a potential downside of 6.76%. Given Seer's stronger consensus rating and higher probable upside, research analysts plainly believe Seer is more favorable than Simulations Plus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Seer	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
Simulations Plus	1 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.88

Simulations Plus has higher revenue and earnings than Seer. Seer is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Seer	$16.58M	6.95	-$73.60M	-$1.22	N/A
Simulations Plus	$82.06M	4.56	-$64.72M	$0.40	46.25

75.2% of Seer shares are owned by institutional investors. Comparatively, 78.1% of Simulations Plus shares are owned by institutional investors. 11.3% of Seer shares are owned by insiders. Comparatively, 19.1% of Simulations Plus shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Simulations Plus had 2 more articles in the media than Seer. MarketBeat recorded 3 mentions for Simulations Plus and 1 mentions for Seer. Seer's average media sentiment score of 1.82 beat Simulations Plus' score of 0.40 indicating that Seer is being referred to more favorably in the media.

Company	Overall Sentiment
Seer	Very Positive
Simulations Plus	Neutral

Summary

Simulations Plus beats Seer on 10 of the 16 factors compared between the two stocks.

How does Seer compare to Quantum-Si?

Seer (NASDAQ:SEER) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

In the previous week, Quantum-Si had 4 more articles in the media than Seer. MarketBeat recorded 5 mentions for Quantum-Si and 1 mentions for Seer. Seer's average media sentiment score of 1.82 beat Quantum-Si's score of 0.40 indicating that Seer is being referred to more favorably in the media.

Company	Overall Sentiment
Seer	Very Positive
Quantum-Si	Neutral

Seer currently has a consensus target price of $4.00, indicating a potential upside of 92.31%. Quantum-Si has a consensus target price of $2.50, indicating a potential upside of 79.86%. Given Seer's stronger consensus rating and higher possible upside, analysts clearly believe Seer is more favorable than Quantum-Si.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Seer	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Seer has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.21, meaning that its stock price is 221% more volatile than the broader market.

75.2% of Seer shares are owned by institutional investors. Comparatively, 39.9% of Quantum-Si shares are owned by institutional investors. 11.3% of Seer shares are owned by company insiders. Comparatively, 22.0% of Quantum-Si shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Seer has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Seer	$16.58M	6.95	-$73.60M	-$1.22	N/A
Quantum-Si	$2.44M	124.69	-$101.34M	-$0.46	N/A

Seer has a net margin of -478.05% compared to Quantum-Si's net margin of -6,138.26%. Seer's return on equity of -27.23% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Seer	-478.05%	-27.23%	-23.99%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

Summary

Seer beats Quantum-Si on 11 of the 17 factors compared between the two stocks.

How does Seer compare to Nautilus Biotechnology?

Seer (NASDAQ:SEER) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Nautilus Biotechnology has lower revenue, but higher earnings than Seer. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Seer	$16.58M	6.95	-$73.60M	-$1.22	N/A
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.45	N/A

Seer has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market. Comparatively, Nautilus Biotechnology has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market.

Nautilus Biotechnology has a net margin of 0.00% compared to Seer's net margin of -478.05%. Seer's return on equity of -27.23% beat Nautilus Biotechnology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Seer	-478.05%	-27.23%	-23.99%
Nautilus Biotechnology	N/A	-37.58%	-30.83%

Seer presently has a consensus price target of $4.00, indicating a potential upside of 92.31%. Nautilus Biotechnology has a consensus price target of $3.83, indicating a potential upside of 77.47%. Given Seer's stronger consensus rating and higher possible upside, equities analysts plainly believe Seer is more favorable than Nautilus Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Seer	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
Nautilus Biotechnology	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

In the previous week, Seer and Seer both had 1 articles in the media. Seer's average media sentiment score of 1.82 beat Nautilus Biotechnology's score of 0.91 indicating that Seer is being referred to more favorably in the media.

Company	Overall Sentiment
Seer	Very Positive
Nautilus Biotechnology	Positive

75.2% of Seer shares are held by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are held by institutional investors. 11.3% of Seer shares are held by insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Seer beats Nautilus Biotechnology on 10 of the 15 factors compared between the two stocks.

How does Seer compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Seer (NASDAQ:SEER) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 75.2% of Seer shares are held by institutional investors. 26.8% of Standard BioTools shares are held by insiders. Comparatively, 11.3% of Seer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Standard BioTools has a net margin of 100.36% compared to Seer's net margin of -478.05%. Standard BioTools' return on equity of -7.57% beat Seer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard BioTools	100.36%	-7.57%	-6.14%
Seer	-478.05%	-27.23%	-23.99%

Seer has lower revenue, but higher earnings than Standard BioTools. Seer is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard BioTools	$85.33M	2.91	-$74.90M	$0.22	2.87
Seer	$16.58M	6.95	-$73.60M	-$1.22	N/A

Standard BioTools presently has a consensus price target of $1.35, indicating a potential upside of 113.61%. Seer has a consensus price target of $4.00, indicating a potential upside of 92.31%. Given Standard BioTools' higher possible upside, research analysts clearly believe Standard BioTools is more favorable than Seer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Seer	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00

Standard BioTools has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, Seer has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

In the previous week, Standard BioTools and Standard BioTools both had 1 articles in the media. Standard BioTools' average media sentiment score of 1.82 equaled Seer'saverage media sentiment score.

Company	Overall Sentiment
Standard BioTools	Very Positive
Seer	Very Positive

Summary

Standard BioTools beats Seer on 7 of the 13 factors compared between the two stocks.

Get Seer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SEER vs. The Competition

Export

Metric	Seer	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$114.34M	$10.88B	$7.45B	$12.86B
Dividend Yield	N/A	1.45%	2.52%	19.59%
P/E Ratio	-1.69	32.42	274.42	25.24
Price / Sales	8.32	104.88	569.14	75.12
Price / Cash	N/A	27.31	76.68	52.75
Price / Book	0.45	6.05	10.34	5.99
Net Income	-$73.60M	$56.67B	$3.49B	$380.69M
7 Day Performance	-4.84%	-1.19%	-2.63%	-3.48%
1 Month Performance	8.68%	4.08%	-6.90%	-6.02%
1 Year Performance	-6.14%	21.78%	1.90%	-5.75%

Seer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SEER Seer	2.8995 of 5 stars	$2.07 -0.7%	$4.00 +93.7%	-5.9%	$114.34M	$13.75M	N/A	124
TKNO Alpha Teknova	2.3803 of 5 stars	$8.98 +6.3%	$8.00 -10.9%	+51.3%	$480.77M	$40.52M	N/A	158	Analyst Forecast Gap Down
SLP Simulations Plus	0.7812 of 5 stars	$18.50 flat	$17.25 -6.8%	N/A	$374.16M	$82.06M	46.25	213
QSI Quantum-Si	3.5921 of 5 stars	$1.59 +29.9%	$2.50 +57.7%	-35.3%	$343.20M	$2.44M	N/A	145	Gap Down High Trading Volume
NAUT Nautilus Biotechnology	3.0508 of 5 stars	$2.25 +23.7%	$3.83 +70.3%	+129.7%	$290.77M	N/A	N/A	130	News Coverage Positive News Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SEER) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Seer (SEER) Competitors

SEER vs. TKNO, SLP, QSI, NAUT, and LAB

How does Seer compare to Alpha Teknova?

Summary

How does Seer compare to Simulations Plus?

Summary

How does Seer compare to Quantum-Si?

Summary

How does Seer compare to Nautilus Biotechnology?

Summary

How does Seer compare to Standard BioTools?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SEER vs. The Competition

Seer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Seer (SEER) Competitors

SEER vs. TKNO, SLP, QSI, NAUT, and LAB

How does Seer compare to Alpha Teknova?

Is SEER or TKNO more profitable?

Do analysts prefer SEER or TKNO?

Does the media favor SEER or TKNO?

Do insiders & institutionals have more ownership in SEER or TKNO?

Which has more volatility and risk, SEER or TKNO?

Which has higher earnings and valuation, SEER or TKNO?

Summary

How does Seer compare to Simulations Plus?

Which has more volatility and risk, SEER or SLP?

Is SEER or SLP more profitable?

Do analysts recommend SEER or SLP?

Which has preferable earnings & valuation, SEER or SLP?

Do insiders and institutionals believe in SEER or SLP?

Does the media favor SEER or SLP?

Summary

How does Seer compare to Quantum-Si?

Does the media favor SEER or QSI?

Do analysts recommend SEER or QSI?

Which has more volatility & risk, SEER or QSI?

Do insiders & institutionals believe in SEER or QSI?

Which has stronger valuation & earnings, SEER or QSI?

Is SEER or QSI more profitable?

Summary

How does Seer compare to Nautilus Biotechnology?

Which has better earnings and valuation, SEER or NAUT?

Which has more risk and volatility, SEER or NAUT?

Is SEER or NAUT more profitable?

Do analysts recommend SEER or NAUT?

Does the media favor SEER or NAUT?

Do insiders and institutionals believe in SEER or NAUT?

Summary

How does Seer compare to Standard BioTools?

Do institutionals and insiders believe in LAB or SEER?

Is LAB or SEER more profitable?

Which has preferable earnings & valuation, LAB or SEER?

Do analysts recommend LAB or SEER?

Which has more volatility & risk, LAB or SEER?

Does the media refer more to LAB or SEER?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SEER vs. The Competition

Seer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools